S 701 United States Senate · 117th Congress

Allergy Testing Access Act of 2021

Summary
Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2021
Committee Review
Floor Vote
President
Introduced Mar 11, 2021 Last action Mar 11, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 11, 2021
Committee
Read twice and referred to the Committee on Finance.
upper
Mar 11, 2021
Introduced
Introduced in Senate
upper
1 primary · 7 co-sponsors

Sponsors